XNYS
ELV
Market cap86bUSD
Oct 08, Last price
400.94USD
1D
-0.83%
1Q
-3.67%
Jan 2017
178.88%
IPO
1,814.71%
Name
Elevance Health Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Anthem, Inc. is a U.S.-based health benefits corporation that operates through its various subsidiary companies. Its operations are structured across four main divisions: Commercial & Specialty Business, Government Business, IngenioRx, and a general 'Other' category. The company provides a wide array of network-based managed care health plans, catering to diverse clientele including large and small employer groups, individual consumers, and participants in the Medicaid and Medicare programs. Its comprehensive managed care portfolio encompasses various options such as Preferred Provider Organizations (PPOs), Health Maintenance Organizations (HMOs), Point-of-Service (POS) plans, traditional indemnity coverage, and hybrid models like consumer-driven health plans, alongside specialized hospital-only and limited benefit offerings. Furthermore, Anthem offers a suite of managed care services for self-funded clients, including claims administration, underwriting, stop-loss insurance, actuarial analysis, access to its provider network, medical and disease management programs, wellness initiatives, and other administrative support. Beyond core health plans, the company delivers various specialty insurance products and services, including pharmacy benefits management (PBM), dental, vision, life, and disability insurance, as well as personalized healthcare solutions powered by analytics. It also serves the federal government through the Federal Employee Program and functions as a licensed entity of the Blue Cross and Blue Shield Association. By the close of 2021, specifically December 31st, its affiliated health plans collectively covered 45 million medical members. Tracing its origins back to its founding in Indianapolis, Indiana, in 1944, the company was initially named WellPoint, Inc. before rebranding as Anthem, Inc. in December 2014.
Related entities
Subsidiaries (60)
MMM HEALTHCARE, LLC
MMM MULTI HEALTH, LLC
OPTIMUM HEALTHCARE, INC.
PMC MEDICARE CHOICE, LLC
ROCKY MOUNTAIN HOSPITAL AND MEDICAL SERVICE, INC
SIMPLY HEALTHCARE PLANS, INC.
Wellpoint District Of Columbia, Inc.
WELLPOINT HEALTH PLANS, INC.
Wellpoint Insurance Company
WELLPOINT INSURANCE SERVICES, INC.
WELLPOINT IOWA, INC.
Wellpoint Life And Health Insurance Company
WELLPOINT MARYLAND, INC.
WELLPOINT NEW JERSEY, INC.
Wellpoint New Mexico, Inc.
WELLPOINT OF NY, LLC
Wellpoint Tennessee, Inc.
WELLPOINT TEXAS, INC.
WELLPOINT WASHINGTON, INC.
WELLPOINT WEST VIRGINIA, INC.
Key people
President, Chief Executive Officer, Director · since 2017
Chief Financial Officer, Executive Vice President · since 2023
Peter Haytaian
Executive Vice President and President, Carelon and CarelonRx · since 2021
Charles Kendrick
Executive Vice President and President, Commercial and Specialty Health Benefits · since 2023
Ratnakar Lavu
Executive Vice President and Chief Digital Information Officer · since 2024
Executive Vice President and President, Government Health Benefits · since 2023
Ronald Penczek
Chief Accounting Officer, Controller · since 2015
R. Kerry Clark
Independent Director · since 2014
Independent Director · since 2021
Independent Director · since 2011
Independent Director · since 2014
Independent Director · since 2018
Independent Director · since 2017
Independent Chairman of the Board · since 2025
Ryan Schneider
Independent Director · since 2019
Independent Director · since 2026
Independent Director · since 2022
IPO date
Oct 30, 2001
Employees
102,300
Domiciled in
US
Incorporated in
US
Legal address
C/O KATHLEEN S KIEFER
220 VIRGINIA AVENUE
INDIANAPOLIS, IN 46204
US
220 VIRGINIA AVENUE
INDIANAPOLIS, IN 46204
US
Headquarters
220 VIRGINIA AVENUE
INDIANAPOLIS, IN 46204
US
INDIANAPOLIS, IN 46204
US
Previous name
ANTHEM, INC.
Previous name
WELLPOINT, INC.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||